Total Payments
$3,418
2024 Payments
$142.81
Companies
20
Transactions
188
Medicare Patients
905
Medicare Billing
$239,172
Payment Breakdown by Category
Food & Beverage$3,407 (99.7%)
Education$10.79 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,407 | 186 | 99.7% |
| Education | $10.79 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $533.92 | 18 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $455.21 | 25 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $394.44 | 27 | $0 (2021) |
| Shire North American Group Inc | $333.96 | 18 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $246.49 | 21 | $0 (2019) |
| Alkermes, Inc. | $242.95 | 13 | $0 (2023) |
| Allergan, Inc. | $217.88 | 15 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $215.55 | 11 | $0 (2019) |
| Lundbeck LLC | $124.99 | 7 | $0 (2019) |
| Amgen Inc. | $103.67 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $142.81 | 7 | Vanda Pharmaceuticals Inc. ($45.11) |
| 2023 | $125.61 | 6 | ITI, Inc. ($70.24) |
| 2022 | $40.61 | 2 | Otsuka America Pharmaceutical, Inc. ($24.41) |
| 2021 | $137.09 | 3 | Neurocrine Biosciences, Inc. ($124.97) |
| 2020 | $335.58 | 14 | Neurocrine Biosciences, Inc. ($210.78) |
| 2019 | $876.55 | 58 | Otsuka America Pharmaceutical, Inc. ($193.91) |
| 2018 | $801.48 | 51 | Shire North American Group Inc ($167.32) |
| 2017 | $958.11 | 47 | Sunovion Pharmaceuticals Inc. ($148.31) |
All Payment Transactions
188 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/17/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Neurology | ||||||
| 05/17/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), REXULTI | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: PSYCHIATRY | ||||||
| 04/19/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 04/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: PSYCHIATRY | ||||||
| 04/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: NEUROSCIENCE | ||||||
| 03/04/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: SCHIZOPHRENIA | ||||||
| 01/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: PSYCHIATRY | ||||||
| 11/17/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: PSYCHIATRY | ||||||
| 11/17/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), REXULTI | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: PSYCHIATRY | ||||||
| 10/20/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: PSYCHIATRY | ||||||
| 06/16/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: PSYCHIATRY | ||||||
| 03/22/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: NEUROSCIENCE | ||||||
| 01/28/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: CNS | ||||||
| 11/18/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: PSYCHIATRY | ||||||
| 10/19/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $8.68 | General |
| Category: CNS | ||||||
| 10/06/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $3.44 | General |
| Category: CNS | ||||||
| 09/07/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: NEUROLOGY | ||||||
| 10/15/2020 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $14.54 | General |
| Category: Addiction Medicine | ||||||
| 06/24/2020 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: NEUROLOGY | ||||||
| 05/29/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/20/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: NEUROSCIENCE | ||||||
| 03/24/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: NEUROSCIENCE | ||||||
| 03/18/2020 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: NEUROLOGY | ||||||
| 03/06/2020 | Alkermes, Inc. | Vivitrol (Drug) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 218 | 638 | $139,825 | $50,607 |
| 2022 | 4 | 238 | 954 | $180,550 | $70,201 |
| 2021 | 5 | 262 | 920 | $175,900 | $71,959 |
| 2020 | 4 | 187 | 734 | $132,045 | $46,405 |
Total Patients
905
Total Services
3,246
Medicare Billing
$239,172
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 96 | 355 | $71,000 | $25,496 | 35.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 148 | $44,300 | $15,026 | 33.9% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 50 | 101 | $12,625 | $5,290 | 41.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 34 | $11,900 | $4,795 | 40.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 92 | 372 | $74,400 | $27,151 | 36.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 82 | 402 | $50,250 | $22,966 | 45.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 48 | 144 | $43,300 | $15,180 | 35.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 36 | $12,600 | $4,904 | 38.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 91 | 337 | $67,400 | $25,462 | 37.8% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 86 | 414 | $51,750 | $24,361 | 47.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 46 | 105 | $31,500 | $11,883 | 37.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 21 | 46 | $16,250 | $7,040 | 43.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 18 | 18 | $9,000 | $3,213 | 35.7% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 69 | 353 | $44,125 | $20,364 | 46.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 66 | 257 | $50,620 | $15,270 | 30.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 38 | 109 | $32,150 | $9,296 | 28.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 14 | 15 | $5,150 | $1,475 | 28.6% |
About Dr. Cynthia Carter, MD
Dr. Cynthia Carter, MD is a Neurology healthcare provider based in Cambridge, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871695072.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cynthia Carter, MD has received a total of $3,418 in payments from pharmaceutical and medical device companies, with $142.81 received in 2024. These payments were reported across 188 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($3,407).
As a Medicare-enrolled provider, Carter has provided services to 905 Medicare beneficiaries, totaling 3,246 services with total Medicare billing of $239,172. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Cambridge, MA
- Active Since 09/01/2006
- Last Updated 02/18/2010
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1871695072
Products in Payments
- INGREZZA (Drug) $533.92
- LATUDA (Drug) $394.44
- Trintellix (Drug) $301.22
- VRAYLAR (Drug) $252.98
- REXULTI (Drug) $249.43
- MYDAYIS (Drug) $210.31
- ABILIFY MAINTENA (Drug) $199.89
- INVEGA SUSTENNA (Drug) $168.20
- Vivitrol 380 mg (Drug) $133.96
- VYVANSE (Drug) $123.65
- CAPLYTA (Drug) $121.03
- Nplate (Biological) $103.67
- AUSTEDO (Drug) $81.08
- TRINTELLIX (Drug) $77.12
- BELSOMRA (Drug) $44.60
- Zubsolv (Drug) $43.54
- ARISTADA (Drug) $40.46
- Fanapt (Drug) $35.50
- ABILIFY ASIMTUFII (Drug) $35.09
- SUBOXONE SUBLINGUAL FILM (Drug) $33.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Cambridge
Dr. Paul Mathew, M.d, M.D
Neurology — Payments: $219,504
Neurology $219,504
Dr. Priyantha Herath, Md Phd, MD PHD
Neurology — Payments: $23,561
Neurology $23,561
Dr. Oscar Soto, Md, MD
Neurology — Payments: $13,289
Neurology $13,289
Dr. Tony Ho, M.d, M.D
Neurology — Payments: $6,655
Neurology $6,655
Nancy Ann Simonian, M.d, M.D
Neurology — Payments: $155.80
Neurology $155.80
Dr. Michael Arena, Md, MD
Neurology — Payments: $124.33
Neurology $124.33